British vaccination controversy to resurface in UK Parliament days before May’s EU announcement

The British vaccination controversy is set to resurface in the UK Parliament, just two days before Prime Minister Theresa May’s announcement on the transition deal with the EU.

On the eve of parliamentary proceedings May is expected to bring forward an announcement on whether or not the UK will remain in the single market and customs union while transitioning out of the EU.

On Wednesday New South Wales says its Chief Government Medical Advisor has tested positive for meningitis B. Prime Minister Theresa May is expected to today to announce whether or not the UK will remain in the single market and customs union during the transition period, reported the Sydney Morning Herald.

“This is a serious matter, we are in the days of vaccination, and we will be exploring what other evidence we can get to support that,” Aussiesport commentator David Gibson said.

Separate from the UK, New South Wales Health Minister Brad Hazzard issued a statement on Thursday saying a senior State Government physician has tested positive for meningitis B in a potentially preventable disease. The advocacy group Generation NSW says Australia is one of the highest risk countries for meningitis.

Other national authorities from Australia, the United States and Canada have reported similar cases over the last couple of months.

In response to the incident, Aussiesport commentators say the vaccination rate in Australia is important.

“You have to travel that much because you’re not living at home, if you did you could get at least vaccinate at least once in the range of five times a year,” Gibson said.

Earlier this year the UK government was slammed for not including meningitis B vaccinations in routine immunization programs for school children, despite backing from Public Health England and U.S. Centers for Disease Control and Prevention.

Leave a Comment